Trial intelligence / Profile preview

Fosamax Plus D in Postmenopausal Osteoporotic Women

NCT00729651Phase 4Completed

Sponsor
Organon & Co.
Start
Mar 2008
Primary completion
Apr 2009
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

A Phase 4 trial of alendronate + cholecalciferol in osteoporosis, sponsored by Organon & Co.. Started Mar 2008; status: completed.

02

Drugs

alendronate + cholecalciferol
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT00729651.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00729651.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call